Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-31

Clinical Trial Update: Study of Naltrexone for Methamphetamine Addiction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating naltrexone for methamphetamine dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: California Pacific Medical Center Research Institute | Conditions: Methamphetamine Dependence | Phase 2 | Status: COMPLETED